Guangdong Taiantang Pharmaceutical Co.Ltd(002433) : the company’s drugs are selected into the clinical application guide of Chinese patent medicine for the treatment of dominant diseases

Guangdong Taiantang Pharmaceutical Co.Ltd(002433) news: on April 24, the State Administration of traditional Chinese medicine approved the standardization project of the clinical application guide of Chinese patent medicine in the treatment of dominant diseases – the clinical application guide of Chinese patent medicine in the treatment of idiopathic oligospermia and asthenospermia male infertility (2021), which was officially published in the Chinese Journal of integrated traditional and Western medicine, and Guangdong Taiantang Pharmaceutical Co.Ltd(002433) Qilin pill was successfully selected.